| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Review
- Language: English
- [Curr Opin HIV AIDS] 2024 Jul 01; Vol. 19 (4), pp. 212-220. <i>Date of Electronic Publication: </i>2024 Apr 26.
- MeSH Terms: HIV Infections* / prevention & control ; Pre-Exposure Prophylaxis* / methods ; Pre-Exposure Prophylaxis* / economics ; Economics, Behavioral* ; Anti-HIV Agents* / economics ; Anti-HIV Agents* / therapeutic use ; Anti-HIV Agents* / administration & dosage ; Humans ; Canada ; Post-Exposure Prophylaxis / methods ; Post-Exposure Prophylaxis / economics
- References: Sullivan PS, Siegler AJ. What will it take to meet UNAIDS targets for preexposure prophylaxis users? Curr Opin Infect Dis 2022; 35:1–8. ; Serota DP, Rosenberg ES, Sullivan PS, et al. Preexposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study. Clin Infect Dis 2020; 71:574–582. ; Coy KC, Hazen RJ, Kirkham HS, et al. Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017. J Int Aids Soc 2019; 22:e25252. ; Rusie LK, Orengo C, Burrell D, et al. Preexposure prophylaxis initiation and retention in care over 5 years, 2012–2017: are quarterly visits too much? Clin Infect Dis 2018; 67:283–287. ; Poteat T, Wirtz A, Malik M, et al. A gap between willingness and uptake: findings from mixed methods research on HIV prevention among black and Latina transgender women. J Acquir Immune Defic Syndr 2019; 82:131. ; Unigwe I, Goodin A, Lo-Ciganic W-H, et al. Trajectories of pre-exposure prophylaxis (PrEP) adherence among commercially insured individuals. Clin Infect Dis 2023. ciad756 https://doi.org/10.1093/cid/ciad756. (PMID: 10.1093/cid/ciad756) ; Zhang J, Li C, Xu J, et al. Discontinuation, suboptimal adherence, and reinitiation of oral HIV preexposure prophylaxis: a global systematic review and meta-analysis. Lancet HIV 2022; 9:e254–e268. ; Anyasi H, Idemudia A, Badru T, et al. Discontinuation of HIV Pre-Exposure Prophylaxis among people in serodifferent relationships: findings from a programmatic surveillance study within a large-scale HIV program in Nigeria. PREPRINT (Version 1) 2023. ; Delany-Moretlwe S, Flexner C, Bauermeister JA. Advancing use of long-acting and extended delivery HIV prevention and treatment regimens. J Int Aids Soc 2023; 26: (Suppl 2.): e26126. ; Liu AY, Scott HM, Buchbinder SP. New USPSTF guidelines for HIV preexposure prophylaxis: will more choices lead to greater impact? JAMA 2023; 330:699–701. ; Celum C, Grinsztejn B, Ngure K. Preparing for long-acting PrEP delivery: building on lessons from oral PrEP. J Int Aids Soc 2023; 26:e26103. ; Meyers K, Golub SA. Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities. Curr Opin HIV AIDS 2015; 10:290–295. ; Wheeler DP, Fields SD, Beauchamp G, et al. Preexposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study. J Int AIDS Soc 2019; 22:e25223. ; Sullivan PS, Mena L, Elopre L, Siegler AJ. Implementation strategies to increase PrEP uptake in the South. Curr HIV/AIDS Rep 2019; 16:259–269. ; Serota D, Rosenberg E, Thorne A, et al. PrEP persistence and discontinuation in a Cohort of young black men who have sex with men in Atlanta, GA. Age 2019; 39:31. ; Rolle C-P, Onwubiko U, Jo J, et al. PrEP implementation and persistence in a county health department setting in Atlanta, GA. AIDS Behav 2019; 23: (Suppl 3): 296–303. ; Finlayson T, Cha S, Xia M, et al. Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017. MMWR Morb Mortal Wkly Rep 2019; 68:597. ; Shover CL, Javanbakht M, Shoptaw S, et al. HIV preexposure prophylaxis initiation at a large community clinic: differences between eligibility, awareness, and uptake. Am J Public Health 2018; 108:1408–1417. ; Holt M, Lea T, Mao L, et al. Community-level changes in condom use and uptake of HIV preexposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013–17. Lancet HIV 2018; 5:e448–e456. ; Dubov A, Galbo P Jr, Altice FL, Fraenkel L. Stigma and shame experiences by MSM who take PrEP for HIV prevention: a qualitative study. Am J Mens Health 2018; 12:1843–1854. ; Parsons JT, Rendina HJ, Lassiter JM, et al. Uptake of HIV preexposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: the motivational PrEP cascade. J Acquir Immune Defic Syndr 2017; 74:285. ; Mugo NR, Ngure K, Kiragu M, et al. AIDS. PrEP for Africa: what we have learnt and what is needed to move to program implementation. Curr Opin HIV AIDS 2016; 11:80. ; Martín M, Valiña MD. Heuristics, biases and the psychology of reasoning: state of the art. Psychology 2023; 14:264–294. ; Gilovich T, Griffin D, Kahneman D. Heuristics and biases: the psychology of intuitive judgment. Cambridge: Cambridge University Press; 2002. ; Mansergh G, Sullivan PS, Kota KK, et al. Preexposure prophylaxis in the era of emerging methods for men who have sex with men in the USA: the HIV Prevention Cycle of Care model. Lancet HIV 2022. ; Sullivan PS, Siegler AJ. Getting preexposure prophylaxis (PrEP) to the people: opportunities, challenges and emerging models of PrEP implementation. Sex Health 2018; 15:522–527. ; Rolle C-P, Rosenberg ES, Siegler AJ, et al. Challenges in translating PrEP interest into uptake in an observational study of young black MSM. J Acquir Immune Defic Syndr 2017; 76:250–258. ; Thaler RH. Behavioral economics: past, present, and future. Am Econ Rev 2016; 106:1577–1600. ; Shafir E. The behavioral foundations of public policy. Princeton: Princeton University Press; 2013. ; World Scientific, Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Handbook of the fundamentals of financial decision making: part I. 2013; 99–127. ; Loewenstein GF, Weber EU, Hsee CK, et al. Risk as feelings. Psychol Bull 2001; 127:267–286. ; Bitzer S, Park H, Maess B, et al. Representation of perceptual evidence in the human brain assessed by fast, within-trial dynamic stimuli. Front Hum Neurosci 2020; 14:9. ; Fouragnan EF, Chau BK, Folloni D, et al. The macaque anterior cingulate cortex translates counterfactual choice value into actual behavioral change. Nat Neurosci 2019; 22:797–808. ; Kolling N, Wittmann M, Rushworth MF. Multiple neural mechanisms of decision making and their competition under changing risk pressure. Neuron 2014; 81:1190–1202. ; Ernst M, Paulus MP. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry 2005; 58:597–604. ; Kawachi I. Berkman LF, Kawachi I, Glymour MM. Applications of behavioral economics to improve health. Oxford University Press, Social epidemiology. Oxford:2014. ; Princeton university press, Camerer CF, Loewenstein G, Rabin M. Advances in behavioral economics. 2004; Princeton,. ; Martin G, Pear JJ. Behavior modification: what it is and how to do it. UK: Routledge; 2019. ; Loewenstein G, Asch DA, Friedman JY, et al. Can behavioural economics make us healthier? BMJ 2012; 344:e3482. ; Elsevier, Cawley J, Ruhm CJ. The economics of risky health behaviors. Handbook of health economics. 2011; 95–199. ; Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA 2007; 298:2415–2417. ; Thorgeirsson T, Kawachi I. Behavioral economics: merging psychology and economics for lifestyle interventions. Am J Prevent Med 2013; 44:185–189. ; VanEpps EM, Volpp KG, Halpern SD. A nudge toward participation: improving clinical trial enrollment with behavioral economics. Sci Transl Med 2016; 8:348fs13. ; Volpp KG, Troxel AB, Mehta SJ, et al. Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction: the HeartStrong randomized clinical trial. JAMA Intern Med 2017; 177:1093–1101. ; Milkman KL, Patel MS, Gandhi L, et al. A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment. Proc Natl Acad Sci 2021; 118:e2101165118. ; Patel MS, Asch DA, Rosin R, et al. Framing financial incentives to increase physical activity among overweight and obese adults: a randomized, controlled trial. Ann Intern Med 2016; 164:385–394. ; Keller PA, Harlam B, Loewenstein G, et al. Enhanced active choice: a new method to motivate behavior change. J Consum Psychol 2011; 21:376–383. ; Bordalo P, Gennaioli N, Shleifer A. Salience. Ann Rev Econ 2022; 14:521–544. ; Nielsen CS, Sebald AC, Sørensen PN. Testing for salience effects in choices under risk 2018. ; Frydman C, Mormann MM. The role of salience in choice under risk: an experimental investigation. Presented at: SSRN; 15 November 2018. Available at: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2778822 . [Accessed 23 December 2023]. ; Bordalo P, Gennaioli N, Shleifer A. Salience theory of choice under risk. Quarterly J Econ 2012; 127:1243–1285. ; Chetty R, Looney A, Kroft K. Salience and taxation: theory and evidence. Am Econ Rev 2009; 99:1145–1177. ; Linnemayr S. HIV prevention through the lens of behavioral economics (draft). J Acquir Immune Defic Syndr 2015; 68:e61. ; Roy Paladhi U, Katz DA, Farquhar C, et al. Using behavioral economics to support PrEP adherence for HIV prevention. Curr HIV/AIDS Rep 2022; 19:409–414. ; Andrawis A, Tapa J, Vlaev I, et al. Applying behavioural insights to HIV prevention and management: a scoping review. Curr HIV/AIDS Rep 2022; 19:358–374. ; Kahneman D. Maps of bounded rationality: psychology for behavioral economics. Am Econ Rev 2003; 93:1449–1475. ; Keen P, Hammoud MA, Bourne A, et al. Use of HIV preexposure prophylaxis (PrEP) associated with lower HIV anxiety among gay and bisexual men in Australia who are at high risk of HIV infection: Results from the Flux Study. JAIDS J Acquir Immune Defic Syndr 2020; 83:119–125. ; Willie TC, Monger M, Nunn A, et al. ‘PrEP's just to secure you like insurance’: a qualitative study on HIV preexposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi. BMC Infect Dis 2021; 21:1–12. ; Edeza A, Karina Santamaria E, Valente PK, et al. Experienced barriers to adherence to preexposure prophylaxis for HIV prevention among MSM: a systematic review and meta-ethnography of qualitative studies. AIDS Care 2021; 33:697–705. ; Zimmermann HM, Eekman SW, Achterbergh RC, et al. Motives for choosing, switching and stopping daily or event-driven preexposure prophylaxis-a qualitative analysis. Afr J Reprod Gynaecol Endosc 2019; 22:e25389. ; Felsher M, Szep Z, Krakower D, et al. ‘I Don’t Need PrEP Right Now’: a qualitative exploration of the barriers to PrEP care engagement through the application of the Health Belief Model. AIDS Educ Prevent 2018; 30:369–381. ; Young I, Flowers P, McDaid LM. Barriers to uptake and use of preexposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ open 2014; 4:e005717. ; Underhill K, Morrow KM, Colleran C, et al. Explaining the efficacy of preexposure prophylaxis (PrEP) for HIV prevention: a qualitative study of message framing and messaging preferences among US men who have sex with men. AIDS Behav 2016; 20:1514–1526. ; Rosen JG, Toomre T, To C, et al. Communicative appeals and messaging frames in visual media for HIV preexposure prophylaxis promotion to cisgender and transgender women. Culture, Health Sexuality 2023; 25:1007–1023. ; Bryant J, Baxter L, Hird S. Nonoccupational postexposure prophylaxis for HIV: a systematic review. Health Technol Asses 2009; 13:1–82. ; Bourry O, Brochard P, Souquiere S, et al. Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir. AIDS 2009; 23:447–454. ; Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the US Department of Health and Human Services. MMWR Recomm Rep 2005; 54:1–20. ; Pinkerton SD, Martin JN, Roland ME, et al. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Arch Intern Med 2004; 164:46–54. ; Kahn JO, Martin JN, Roland ME, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study. J Infect Dis 2001; 183:707–714. ; Otten RA, Smith DK, Adams DR, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000; 74:9771–9775. ; Tsai C-C, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol 1998; 72:4265–4273. ; Hou J, Wu Y, Xie L, et al. Postexposure prophylaxis: an underutilized biomedical HIV prevention method among gay, bisexual and other men who have sex with men in China. AIDS Care 2020; 32:1573–1580. ; Wang Z, Zou H. The uptake of nonoccupational HIV postexposure prophylaxis among MSM: a systematic review and meta-analysis. UK: BMJ Publishing Group Ltd; 2019. ; Jain S, Krakower DS, Mayer KH. The transition from postexposure prophylaxis to preexposure prophylaxis: an emerging opportunity for biobehavioral HIV prevention. Clin Infect Dis 2015; 60: (Suppl_3): S200–S204. ; Dominguez KL, Smith DK, Thomas V, et al. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. Centers for Disease Control and Prevention. 2023. Available at: https://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf . [Accessed 23 December 2023]. ; Naqvi N, Shiv B, Bechara A. The role of emotion in decision making: a cognitive neuroscience perspective. Curr Dir Psychol Sci 2006; 15:260–264. ; Koblin BA, Usher D, Nandi V, et al. Postexposure prophylaxis awareness, knowledge, access and use among three populations in New York City, 2016–17. AIDS Behav 2018; 22:2718–2732. ; Hugo JM, Stall RD, Rebe K, et al. Knowledge, attitudes and beliefs regarding post exposure prophylaxis among South African men who have sex with men. AIDS Behav 2016; 20: (Suppl 3): 350–356. ; Thomas R, Galanakis C, Vézina S, et al. Adherence to postexposure prophylaxis (PEP) and incidence of HIV seroconversion in a major North American cohort. PLoS One 2015; 10:e0142534. ; Dolezal C, Frasca T, Giguere R, et al. Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev 2015; 27:289–297. ; McDougal SJ, Alexander J, Dhanireddy S, et al. Nonoccupational postexposure prophylaxis for HIV: 10-year retrospective analysis in Seattle, Washington. PLoS One 2014; 9:e105030. ; Oldenburg CE, Bärnighausen T, Harling G, et al. Adherence to post-exposure prophylaxis for nonforcible sexual exposure to HIV: a systematic review and meta-analysis. AIDS Behav 2014; 18:217–225. ; Alghamdi A, Hempel A, Heendeniya A, et al. HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures. AIDS 2020; 34:433–437. ; Straub DM, Mullins TLK. Nonoccupational postexposure prophylaxis and preexposure prophylaxis for human immunodeficiency virus prevention in adolescents and young adults. Adv Pediatr 2019; 66:245–261. ; Tumarkin E, Heendeniya A, Murphy P, et al. Brief report: HIV postexposure prophylaxis-in-pocket (“PIP”) for individuals with low-frequency, high-risk HIV exposures. JAIDS J Acquir Immune Defic Syndr 2018; 78:20–22. ; Molina J-M, Charreau I, Chidiac C, et al. Postexposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis 2018; 18:308–317. ; Billick MJ, Sheps J, Bogoch II. HIV prevention with postexposure prophylaxis-in-pocket (PIP). BMJ 2023; 382:e076016. ; Billick MJ, Fisher KN, Myers S, et al. PEP-in-pocket (PIP): long-term follow-up of on demand hiv post-exposure prophylaxis. Presented at: The Conference on Retroviruses and Opportunistic Infections (CROI);19–22 February 2023. 2023; Seattle, Washington. Session PrEP AND PEP: ADHERENCE MEASURES AND STIs. Available at: https://www.croiconference.org/abstract/pep-in-pocket-pip-long-term-follow-up-of-on-demand-hiv-postexposure-prophylaxis/ . ; Heendeniya A, Bogoch II. HIV prevention with postexposure prophylaxis-in-pocket. Lancet Public Health 2019; 4:e494. ; Siemieniuk RA, Sivachandran N, Murphy P, et al. Transitioning to HIV preexposure prophylaxis (PrEP) from nonoccupational postexposure prophylaxis (nPEP) in a comprehensive HIV prevention clinic: a prospective cohort study. AIDS Patient Care St 2015; 29:431–436. ; Mayer KH, Allan-Blitz L-T. Postexposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions. Lancet HIV 2023; 10:E816–E824. ; Zucker J, Carnevale C, Richards P, et al. Predictors of disengagement in care for individuals receiving preexposure prophylaxis (PrEP). J Acquir Immune Defic Syndromes 2019; 81:e104. ; O’Byrne P, Orser L, Vandyk A. Immediate PrEP after PEP: results from an observational nurse-led PEP2PrEP study. J Int Assoc Provid AIDS Care 2020; 19:2325958220939763. ; Richardson D, Nichols K, Pickering A, et al. Transitioning from HIV postexposure prophylaxis to preexposure prophylaxis in men who have sex with men. HIV Med 2021; 22:780–781. ; Clifford Rashotte M, Yoong D, Naccarato M, et al. Appropriate usage of postexposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures. Int J STD AIDS 2023; 0: doi:10.1177/09564624231215151. (PMID: 10.1177/09564624231215151) ; Koss CA, Ayieko J, Kabami J, et al. Dynamic choice HIV prevention intervention at outpatient departments in rural Kenya and Uganda: a randomized trial. AIDS 2022; 10:1097. ; Centers for Disease Control and Prevention. Funding Opportunity Announcement PS20-2010: Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States. 2023. Available at: https://www.cdc.gov/hiv/funding/announcements/ps20-2010/index.html . [Accessed 30 November 2023]. ; Anderson AN, Haardörfer R, Holstad MM, et al. A path analysis of patient and Social-Level factors on health literacy and retention in care among African Americans living with HIV. AIDS Behav 2020; 24:1124–1132. ; Baumann KE, Phillips AL, Arya M. Overlap of HIV and low health literacy in the southern USA. Lancet HIV 2015; 2:e269–e270. ; McDaid L, Flowers P, Ferlatte O, et al. Sexual health literacy among gay, bisexual and other men who have sex with men: a conceptual framework for future research. Cult Health Sex 2021; 23:207–223. ; Yu J, Luo W, Xie Y. Sexuality in China: a review and new findings. Chin J Sociol 2022; 8:293–329. ; Lyu J, Shen X, Hesketh T. Sexual knowledge, attitudes and behaviours among undergraduate students in China—implications for sex education. Int J Environ Res Public health 2020; 17:E6716. ; Xie L, Wu Y, Meng S, et al. Risk behavior not associated with self-perception of PrEP candidacy: implications for designing PrEP services. AIDS Behav 2019; 23:2784–2794. ; Wang X, Li J, Sun L, et al. Predictors and highlights for pre and postexposure prophylaxis uptake among men who have sex with men in three large cities in China. Preprint (Version 1) available at Research Square. 2022. ; Maasoumi R, Tavousi M, Zarei F. Development and psychometric properties of sexual health literacy for adults (SHELA) questionnaire. 2019. ; Rüegg R. Decision-making ability: a missing link between health literacy, contextual factors, and health. Health Lit Res Pract 2022; 6:e213–e223. ; Fagley N, Coleman JG, Simon AF. Effects of framing, perspective taking, and perspective (affective focus) on choice. Pers Indiv Differ 2010; 48:264–269. ; Yeater EA, Viken RJ, Hoyt T, et al. Self-other perspective and sexual attitudes affect estimates of sexual risk. Sex Roles 2009; 61:110–119. ; Patterson TL, Semple SJ, Abramovitz D, et al. Impact of time perspectives on texting intervention to reduce HIV/STI transmission among female sex workers in Tijuana and Ciudad Juarez, Mexico. J Behav Med 2019; 42:111–127. ; Deal SB, Stefanidis D, Brunt LM, Alseidi A. Development of a multimedia tutorial to educate how to assess the critical view of safety in laparoscopic cholecystectomy using expert review and crowd-sourcing. Am J Surg 2017; 213:988–990. ; Ong JJ, Booton RD, Tucker JD, et al. Economic evaluation of improving HIV self-testing among MSM in China using a crowdsourced intervention: a cost-effectiveness analysis. AIDS 2023; 37:671–678. ; Matos LA, Lujan RA. Culturally targeted video intervention to increase PrEP use intentions among Latinx sexual minority men: a pilot randomized controlled trial. Hisp Health Care Int 2023; 0: doi:10.1177/15404153231210436. (PMID: 10.1177/15404153231210436) ; Danry V, Pataranutaporn P, Mao Y, et al. Wearable Reasoner: towards enhanced human rationality through a wearable device with an explainable AI assistant. 2020. pp. 1–12. ; Wang C-A, Blohm G, Huang J, et al. Multisensory integration in orienting behavior: pupil size, microsaccades, and saccades. Biol Psychol 2017; 129:36–44. ; Talsma D. Predictive coding and multisensory integration: an attentional account of the multisensory mind. Front Integr Neurosci 2015; 9:19. ; Talsma D, Senkowski D, Soto-Faraco S, Woldorff MG. The multifaceted interplay between attention and multisensory integration. Trends Cogn Sci 2010; 14:400–410. ; Koelewijn T, Bronkhorst A, Theeuwes J. Attention and the multiple stages of multisensory integration: a review of audiovisual studies. Acta Psychol 2010; 134:372–384. ; Heikkilä J, Alho K, Hyvönen H, et al. Audiovisual semantic congruency during encoding enhances memory performance. Exp Psychol 2015; 62:123–130. ; Shams L, Seitz AR. Benefits of multisensory learning. Trends Cogn Sci 2008; 12:411–417. ; George S, Moran E, Duran N, et al. Using animation as an information tool to advance health research literacy among minority participants. Am Med Inform Assoc 2013; 2013:475–483. ; Williams O, Swierad EM. A multisensory multilevel health education model for diverse communities. Int J Environ Res Public Health 2019; 16:E872. ; Hodes R, Vale B, Toska E, et al. ‘Yummy or crummy?’The multisensory components of medicines-taking among HIV-positive youth. Global Public Health 2019; 14:284–299. ; Williams O, Leighton-Herrmann Quinn E, Teresi J, et al. Improving community stroke preparedness in the HHS (Hip-Hop Stroke) randomized clinical trial. Stroke 2018; 49:972–979. ; Namkoong K, Chen J, Leach J, et al. Virtual reality for public health: a study on a VR intervention to enhance occupational injury prevention. J Public Health 2023; 45:136–144. ; Qian J, McDonough DJ, Gao Z. The effectiveness of virtual reality exercise on individual's physiological, psychological and rehabilitative outcomes: a systematic review. Int J Environ Res Public Health 2020; 17:E4133. ; Cornelio P, Velasco C, Obrist M. Multisensory integration as per technological advances: a review. Front Neurosci 2021; 15:652611. ; Canidate S, Hart M. The use of avatar counseling for HIV/AIDS health education: the examination of self-identity in avatar preferences. J Med Internet Res 2017; 19:e365. ; Ramos SR, Warren R, Shedlin M, et al. A framework for using eHealth interventions to overcome medical mistrust among sexual minority men of color living with chronic conditions. Behav Med 2019; 45:166–176. ; Portillo GAO, Fletcher JB, Young LE, et al. Virtual avatars as a new tool for human immunodeficiency virus prevention among men who have sex with men: a narrative review. Mhealth 2023; 9:29. ; Bond KT, Ramos SR. Utilization of an animated electronic health video to increase knowledge of post and preexposure prophylaxis for HIV among African American women: Nationwide cross-sectional survey. JMIR Format Res 2019; 3:e9995. ; Bourne A. The role of fear in HIV prevention. Sigma Research, London School of Hygiene & Tropical Medicine. Available at: http://sigmaresearch.org.uk/files/MiC-briefing-1-Fear.pdf . [Accessed 18 November 2018]. ; Slavin S, Batrouney C, Murphy D. Fear appeals and treatment side-effects: an effective combination for HIV prevention? AIDS Care 2007; 19:130–137. ; Brown TM, Fee E. A role for public health history. Am J Public Health 2004; 94:1851–1853. ; Kok G, Peters G-JY, Kessels LT, et al. Ignoring theory and misinterpreting evidence: the false belief in fear appeals. Health Psychol Rev 2018; 12:111–125. ; Kincaid D, Delate R, Storey J, et al. Closing the gaps in practice and in theory: evaluation of the Scrutinize HIV campaign in South Africa. 2012; Public Communication Campaigns London: Sage Publications Ltd, 305–320. ; Stolow JA, Moses LM, Lederer AM, et al. How fear appeal approaches in COVID-19 health communication may be harming the global community. Health Educ Behav 2020; 47:531–535. ; Jimenez T, Restar A, Helm PJ, et al. Fatalism in the context of COVID-19: perceiving coronavirus as a death sentence predicts reluctance to perform recommended preventive behaviors. SSM Popul Health 2020; 11:100615.
- Substance Nomenclature: 0 (Anti-HIV Agents)
- Entry Date(s): Date Created: 20240430 Date Completed: 20240606 Latest Revision: 20240608
- Update Code: 20240608
|
